Mukka Proteins Limited Amends Insider Trading Code Following Board Approval
Mukka Proteins Limited has amended its insider trading code following Board approval on 12th February 2026, pursuant to SEBI regulations. The comprehensive code defines designated persons, UPSI categories, trading restrictions, pre-clearance requirements, and establishes a digital database maintenance system with strict compliance and penalty provisions.

*this image is generated using AI for illustrative purposes only.
Mukka Proteins Limited has amended its Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders following Board approval on 12th February 2026. The amendment was made pursuant to Regulation 8(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, based on the recommendation of the Audit Committee.
Key Provisions of the Amended Code
The updated code establishes comprehensive guidelines for insider trading regulations and defines various categories of persons subject to these provisions. The code identifies designated persons including promoters, promoter groups, all members of the Board of Directors, executive directors, key executives, and their immediate relatives.
| Category | Details |
|---|---|
| Designated Persons | Promoters, Board members, Executive Directors, Key Executives |
| Coverage | Immediate relatives and insiders with UPSI access |
| Compliance Officer | Kalandan Mohammed Althaf, Whole-Time Director & CFO |
| Contact | +918244252889, investors@mukkaproteins.com |
Definition of Unpublished Price Sensitive Information
The code provides detailed definitions of unpublished price sensitive information (UPSI), which includes information not generally available that could materially affect security prices. Key categories of UPSI encompass:
- Financial results and dividend declarations
- Changes in capital structure and mergers or acquisitions
- Key managerial personnel changes and rating modifications
- Fund raising activities and management control agreements
- Fraud, defaults, or arrests of key personnel
- Regulatory actions and litigation outcomes
Trading Restrictions and Pre-clearance Requirements
The amended code establishes strict trading restrictions for designated persons when in possession of UPSI. All designated persons must obtain pre-clearance before executing any transactions in company securities. The code mandates a minimum holding period of six months for acquired securities and requires submission of transaction reports within two trading days.
| Requirement | Details |
|---|---|
| Pre-clearance | Mandatory for all designated persons |
| Minimum Holding | Six months from acquisition date |
| Reporting Timeline | Within two trading days of transaction |
| Database Maintenance | Eight years preservation period |
Digital Database and Compliance Framework
The Compliance Officer must maintain a structured digital database with time stamping and audit trails containing details of UPSI and persons with whom information is shared. The database must be preserved for at least eight years after completion of relevant transactions. The code also establishes a "Chinese Wall" concept to prevent misuse of confidential information between inside and public areas.
Penalties and Enforcement
Violations of the code may result in disciplinary action, penalties, debarment, suspension, or criminal prosecution. The company must promptly inform stock exchanges of any violations observed by the Board of Directors. The code clarifies that company disciplinary actions do not preclude SEBI and other authorities from taking separate enforcement actions.
The amended code is available on the company's website at https://mukkaproteins.com/policy.php and has been communicated to both NSE and BSE for further dissemination to market participants.
Historical Stock Returns for Mukka Proteins
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.57% | +7.00% | +13.29% | -8.57% | -28.51% | -40.66% |

































